These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5635231)

  • 21. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
    Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C
    Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Two cases of hereditary hemorrhagic telangiectasia showing rapid improvement of epistaxis after combination therapy of estrogen and progesterone].
    Ito S; Hirono S
    Rinsho Ketsueki; 1982 Aug; 23(8):1205-10. PubMed ID: 7143724
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
    Yaniv E; Preis M; Hadar T; Shvero J; Haddad M
    Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.
    Mei-Zahav M; Blau H; Bruckheimer E; Zur E; Goldschmidt N
    J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):58. PubMed ID: 28978360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review.
    Halderman AA; Ryan MW; Clark C; Sindwani R; Reh DD; Poetker DM; Invernizzi R; Marple BF
    Int Forum Allergy Rhinol; 2018 Jun; 8(6):713-728. PubMed ID: 29393992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia.
    Jameson JJ; Cave DR
    Laryngoscope; 2004 Apr; 114(4):705-9. PubMed ID: 15064628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary haemorrhagic telangiectasia (HHT): negotiating between the Scylla of bleeding and Charybdis of thrombosis.
    Ghosh K; Ghosh K
    Thromb Haemost; 2008 Jul; 100(1):162-4. PubMed ID: 18612556
    [No Abstract]   [Full Text] [Related]  

  • 30. An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2.
    Hunter BN; Timmins BH; McDonald J; Whitehead KJ; Ward PD; Wilson KF
    Laryngoscope; 2016 Apr; 126(4):786-90. PubMed ID: 26372311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A modified technique for septodermoplasty in hereditary hemorrhagic telangiectasia.
    Rimmer J; Lund VJ
    Laryngoscope; 2014 Jan; 124(1):67-9. PubMed ID: 23832829
    [No Abstract]   [Full Text] [Related]  

  • 32. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of epistaxis in Osler-Weber-Rendu disease: recurrence of telangiectases within a nasal skin graft.
    McCabe WP; Kelly AP
    Plast Reconstr Surg; 1972 Aug; 50(2):114-8. PubMed ID: 4558109
    [No Abstract]   [Full Text] [Related]  

  • 34. Local oestrogen for recurrent epistaxis caused by familial telangiectasia.
    Tombleson PM
    J R Coll Gen Pract; 1988 May; 38(310):227. PubMed ID: 3210187
    [No Abstract]   [Full Text] [Related]  

  • 35. The natural history of epistaxis in hereditary hemorrhagic telangiectasia.
    AAssar OS; Friedman CM; White RI
    Laryngoscope; 1991 Sep; 101(9):977-80. PubMed ID: 1886446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Taking thalidomide out of rehab.
    Akhurst RJ
    Nat Med; 2010 Apr; 16(4):370-2. PubMed ID: 20376039
    [No Abstract]   [Full Text] [Related]  

  • 37. Domiciliary floseal prevents admission for epistaxis in hereditary hemorrhagic telangiectasia.
    Warner L; Halliday J; James K; de Carpentier J
    Laryngoscope; 2014 Oct; 124(10):2238-40. PubMed ID: 24706356
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
    Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary HaemorrhagicTelangiectasia--A Rare Cause of Severe Anaemia.
    Deshpande P; Bhat S; Karmarkar A
    J Assoc Physicians India; 2014 Dec; 62(12):48-51. PubMed ID: 26259423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
    Flanagan BA; Collins C; Parra S
    Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.